HomeHealthcare & Life SciencesBiotechnology Hereditary Spherocytosis Market

North America Hereditary Spherocytosis Market Size & Outlook, 2026-2034


North America Hereditary Spherocytosis Market Insights

  • Reed Intelligence analysis indicates that the North America Hereditary Spherocytosis Market size, which was USD 170.66 Million in 2025, is projected to attain USD 323.96 Million by 2034.
  • The market is expected to register a CAGR of 7.26% over the period 2026–2034.
  • In 2025, Blood Smear Analysis emerged as the dominant Diagnosis Type based on market size.
  • Blood Smear Analysis is projected to register the fastest growth, positioning it as the most attractive Diagnosis Type segment over the forecast horizon.

Other Key Findings


  • The global Hereditary Spherocytosis Market size saw North America holding a share of 37.51% in 2025.
  • United States is forecasted to account for the leading share of the global market by 2034.
  • In North America, United States is forecasted to be the fastest-expanding market, projected to reach USD 252.78 Million by 2034.

Report Summary

Report Scope Details
Base Year for Study 2025
Study Period 2022-2034
Historical Period 2022-2024
Forecast Period 2026-2034
Market Size In 2025 USD 170.66 Million
Market Size In 2034 USD 323.96 Million
Largest segment Blood Smear Analysis
Units Revenue in USD Million
CAGR 7.26% (2026-2034)
Segmnetation Covered
North America
  1. United States
  2. Canada
Diagnosis Type
  1. Blood Smear Analysis
  2. Osmotic Fragility Test
  3. Genetic Testing
Treatment Type
  1. Splenectomy
  2. Folic Acid Supplementation
  3. Blood Transfusion
  4. Supportive Care
End User
  1. Hospitals
  2. Specialty Clinics
  3. Diagnostic Laboratories
Report Coverage Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends

Related Reports